LOINC
Version 2.67

89987-2Vortioxetine [Presence] in Urine by Screen methodActive

Part Description

LP268226-0   Vortioxetine

Vortioxetine is an antidepressant used to treat major depressive disorder (MDD). It binds to a variety of serotonin receptors and also inhibits the reuptake of serotonin, thereby increasing the amount of 5-HT in the synapse. Vortioxetine may also help reduce symptoms of anxiety. [PMID: 25851751] 
Vortioxetine takes about 2 weeks to reach steady-state concentration in the plasma, and it is primarily metabolized in the liver to an inactive metabolite. Side effects are primarily self-limited and include nausea, headache, and abdominal pain. [PMID: 29920978] Source: Regenstrief LOINC

Fully-Specified Name

Component
Vortioxetine
Property
PrThr
Time
Pt
System
Urine
Scale
Ord
Method
Screen

Additional Names

Short Name
Vortioxetine Ur Ql Scn
Display Name
Vortioxetine Screen Ql (U)

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.65
Last Updated
Version 2.65
Order vs. Observation
Both

Example Answer List LL360-9

Source: Regenstrief Institute

Answer Code Score Answer ID
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value) LA6576-8
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value) LA6577-6

Language Variants Get Info

zh-CNChinese (CHINA)
沃替西汀:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验
it-ITItalian (ITALY)
Vortioxetina:PrThr:Pt:Urine:Ord:Screening
es-ESSpanish (SPAIN)
Vortioxetina:PrThr:Punto temporal:Orina:Ord:Cribado toxicológico

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=89987-2